These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22706845)

  • 1. Growth factor signaling in metastasis: current understanding and future opportunities.
    Lowery FJ; Yu D
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):479-91. PubMed ID: 22706845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ; Halberg N; Yoshida M; Tavazoie SF
    Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Factors and their receptors in cancer metastases.
    Yang SY; Miah A; Pabari A; Winslet M
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):531-8. PubMed ID: 21196186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the metastasis paradigm from scientific theory to clinical oncology.
    Dong F; Budhu AS; Wang XW
    Clin Cancer Res; 2009 Apr; 15(8):2588-93. PubMed ID: 19351761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
    BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors and their receptors in metastasis.
    Radinsky R
    Semin Cancer Biol; 1991 Jun; 2(3):169-77. PubMed ID: 1655117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of epidermal growth factor receptor in cancer metastasis and microenvironment.
    Sasaki T; Hiroki K; Yamashita Y
    Biomed Res Int; 2013; 2013():546318. PubMed ID: 23986907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.
    Vaidya KS; Harihar S; Phadke PA; Stafford LJ; Hurst DR; Hicks DG; Casey G; DeWald DB; Welch DR
    J Biol Chem; 2008 Oct; 283(42):28354-60. PubMed ID: 18664570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
    Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
    Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
    Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
    Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell signalling: growth factors and tyrosine kinase receptors.
    Perona R
    Clin Transl Oncol; 2006 Feb; 8(2):77-82. PubMed ID: 16632420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
    Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
    Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
    Mimeault M; Batra SK
    Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
    Yu Y; Merlino G
    Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.
    Langley RR; Fidler IJ
    Int J Cancer; 2011 Jun; 128(11):2527-35. PubMed ID: 21365651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapies in metastatic esophageal cancer: advances over the past decade.
    Mohamed A; El-Rayes B; Khuri FR; Saba NF
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):186-96. PubMed ID: 24582516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.
    Fidler IJ
    Nat Rev Cancer; 2003 Jun; 3(6):453-8. PubMed ID: 12778135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.